ArticleMedical hypothesis, discovery & innovation ophthalmology journal2018
The Effect of Artificial Tear Preparations with Three Different Ingredients on Contrast Sensitivity in Patients with Dry Eye Syndrome.
Article in Medical hypothesis, discovery & innovation ophthalmology journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 3 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study was conducted to investigate the effects of Artificial Tear Preparations (ATP) with three different ingredients on contrast sensitivity in patients with dry eye syndrome. Contrast sensitivity measurements were obtained before and 5, 15, 30, 60, and 90 minutes after administering three different ATPs, containing dextran 70, hydroxypropyl methylcellulose (ATP-1), polyvinyl alcohol-povidone (ATP-2) and carbomer (ATP-3) to one eye of 20 patients with dry eye syndrome, who had been divided to three groups. Contrast sensitivity measurements were obtained at 1.5, 3, 6, 12, and 18 spatial frequencies (cpd). Compared with the baseline measurements, ATP-1 provided a significant increase of 1.5 and 3 cpd at the 15th minute, 12 cpd at the 60th minute, and 18 cpd at the 30th minute, ATP-2 significantly increased contrast sensitivity compared with the baseline at the 15th, 30th, 60th, and 90th minute measurements, recorded as 1.5, 3, 12, and 18 cpd, and ATP-3 provided significant increases of 18 cpd at 60th and 90th minute measurements compared with the baseline. In conclusion, while ATP-2 increased the majority of contrast sensitivity measurements both at early, mid, and late terms, the ATP-1 and ATP-3 were found to be effective on mid-term and late-term contrast sensitivity measurements, respectively.
Indexed as
Identifiers
30250858PMC6146240W3014194333What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.